Advanced Ovarian Carcinoma

general

An ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.

18

Centers

28

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

NameCenters
Advanced Platinum-Resistant Ovarian Carcinoma—

Top Centers for Advanced Ovarian Carcinoma(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
High-Volume Research Center
74.0
2
Boston University Cancer CenterBoston, MA
High-Volume Research Center
71.5
3
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
62.8
4
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
62.8
5
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
Active Research Program
62.8
6
OHSU Knight Cancer InstitutePortland, OR
NCI Comprehensive
Active Research Program
62.8
7
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
62.8
8
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
62.8
9
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
44.0
10
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
Active Research Program
44.0
11
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
44.0
12
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
44.0
13
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
44.0
14
University of Illinois Cancer CenterChicago, IL
Active Research Program
44.0
15
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
44.0
16
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
44.0
17
Princess Margaret Cancer CentreToronto, ON
Active Research Program
44.0
18
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
NCI Comprehensive
31.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →